Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.480
-0.160 (-9.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ocugen Inc
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
22
23
Next >
Prepare for Another Pop to $15 With Ocugen Stock
August 10, 2021
Even while Ocugen changes up its strategy in the U.S., the company is pushing for approval elsewhere and OCGN stock can still move higher.
Via
InvestorPlace
Exposures
COVID-19
Ocugen, Inc. (OCGN) Q2 2021 Earnings Call Transcript
August 06, 2021
OCGN earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Ocugen Is Rallying Today
August 06, 2021
Finally, a bit of good news for this oversold biotech.
Via
The Motley Fool
Exposures
COVID-19
Ocugen Stock Is Creeping Up To This Resistance Level
August 05, 2021
Ocugen Inc. (NASDAQ: OCGN) shares were trading higher Thursday in sympathy with other coronavirus vaccine stocks. Vaccine stocks are likely moving after Moderna Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
OCGN Stock: 2 Big Reasons Ocugen Is Gaining Today
August 05, 2021
Today, a couple of key catalysts are driving OCGN stock higher by double digits, as investors speculate on what may be announced tomorrow.
Via
InvestorPlace
Exposures
COVID-19
Analyzing Ocugen's Unusual Options Activity
August 03, 2021
Shares of Ocugen (NASDAQ:OCGN) saw some unusual options a...
Via
Benzinga
Earnings Scheduled For August 6, 2021
August 06, 2021
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million....
Via
Benzinga
2 Ultra-Risky Stocks I Wouldn't Buy With Free Money
August 03, 2021
Even if you aren't risk-averse, you should think long and hard about holding these stocks.
Via
The Motley Fool
Throw in The Towel, Ocugen Stock is Not Coming Back
August 02, 2021
The Delta variant may be extending the Covid-19 health crisis, but don't assume that means Covaxin can still change the game for OCGN stock
Via
InvestorPlace
Exposures
COVID-19
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
July 29, 2021
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
Via
InvestorPlace
Exposures
COVID-19
Why Ocugen Stock Rose, Then Slipped Today
July 26, 2021
An analyst launched coverage of the stock with an extremely bullish note, however...
Via
The Motley Fool
Exposures
COVID-19
Ocugen Likely Can’t Get a Boost From the FDA Until 2023
July 22, 2021
It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
54 Biggest Movers From Yesterday
July 20, 2021
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon...
Via
Benzinga
Why Shares of Ocugen Climbed Today
July 19, 2021
The delta variant is lifting the tide of companies associated with COVID testing and prevention.
Via
The Motley Fool
Topics
Death
Exposures
Death
Ocugen Stock Is Well Past Its Expiration Date and It Shows
July 16, 2021
There won’t be a market for COVAXIN in the US as vaccination rates continue moving up. OCGN stock doesn’t even warrant the price of a dollar.
Via
InvestorPlace
Why Ocugen Shares Are Rallying Today
July 15, 2021
Ocugen, Inc. (NASDAQ: OCGN) shares were advancing strongly Thursday after the biopharma issued a regulatory update. Pennsylvania-based Ocugen said it has initiated a rolling...
Via
Benzinga
Why Ocugen Stock Skyrocketed 339% in the First Half of 2021
July 14, 2021
The big jump resulted from the company's partnership with Bharat Biotech to commercialize COVID-19 vaccine Covaxin.
Via
The Motley Fool
Exposures
COVID-19
Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering
July 12, 2021
While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate.
Via
InvestorPlace
Exposures
COVID-19
Why Shares of Ocugen Are Dropping Today
July 09, 2021
Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved.
Via
The Motley Fool
Exposures
COVID-19
The Outlook for Ocugen Stock Has Deteriorated Further
July 07, 2021
Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.
Via
InvestorPlace
Exposures
COVID-19
What's Next For Ocugen Stock As It Nears Key Resistance Level?
July 06, 2021
Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported...
Via
Benzinga
Exposures
COVID-19
42 Stocks Moving In Tuesday's Mid-Day Session
July 06, 2021
Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...
Via
Benzinga
3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory
July 06, 2021
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.
Via
InvestorPlace
OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today
July 06, 2021
OCGN stock is racing higher this morning following better-than-expected results from Ocugen's vaccine partner. Here is what you need to know.
Via
InvestorPlace
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 06, 2021
Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella...
Via
Benzinga
Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79%
July 06, 2021
Armed with new data from its development partner Bharat Biotech, Ocugen Inc (NASDAQ: OCGN) plans to press ahead with plans to file for approval of their COVID-19...
Via
Benzinga
Exposures
COVID-19
28 Stocks Moving in Tuesday's Pre-Market Session
July 06, 2021
Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE...
Via
Benzinga
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
July 06, 2021
Growing trends involving OCGN stock suggest that the bears may have the upper hand this time.
Via
InvestorPlace
Exposures
COVID-19
Ocugen Has Had a Good Run, but the Math Says It’s Over
July 06, 2021
Ocugen was a penny stock is up 180% for the year. But all good things must come to an end. And it’s time to let go of OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
3 Tips for Coronavirus Investing Right Now
July 05, 2021
Whether you're a cautious or aggressive investor, there's something for you in this space.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
22
23
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.